Leone, Caterina http://orcid.org/0000-0002-8828-361X
Di Stefano, Giulia
Di Pietro, Giuseppe
Bloms-Funke, Petra
Boesl, Irmgard
Caspani, Ombretta
Chapman, Sonya C.
Finnerup, Nanna Brix
Garcia-Larrea, Luis
Li, Tom
Goetz, Marcus
Mouraux, André
Pelz, Bernhard
Pogatzki-Zahn, Esther
Schilder, Andreas
Schnetter, Erik
Schubart, Karin
Tracey, Irene
Troconiz, Inaki F.
Van Niel, Hans
Hernandez, Jose Miguel Vela
Vincent, Katy
Vollert, Jan
Wanigasekera, Vishvarani
Wittayer, Matthias
Phillips, Keith G.
Truini, Andrea
Treede, Rolf-Detlef
Funding for this research was provided by:
Innovative Medicines Initiative (777500)
Article History
Received: 6 December 2021
Accepted: 26 May 2022
First Online: 5 September 2022
Declarations
:
: The study has been approved by the IEC of the following sites: Comitato Etico Sapienza Università di Roma (Italy), the Comité d’Ethique hospitalo-facultaire of the Cliniques universitaires Saint-Luc (Belgium), the Ethik-Kommission II der Universität Heidelberg (Germany).Written informed consent will be provided by each participant before the start of study assessments or the intervention.
: Not applicable.
: CL, GDS, AM, OC, LGL, AT, IT, IFT, VW, and MW declare they have no competing interests. PBF was an employee of Grünenthal when she contributed to the study protocol, and reports consultancy fees from Consultech. IB is an employee of Grünenthal. SCC is an employee of Eli Lilly and Company. TL is an employee of Teva Pharmaceutical. NBF reports personal fees from Almirall, NeuroPN, Novartis Pharma, and Vertex and has undertaken consultancy work for Aarhus University with remunerated work for Biogen, Merz, and Confo Therapeutics, outside the submitted work. EPZ reports fees from Mundipharma and Grünenthal, outside the submitted work. KP is an employee of Eli Lilly and Company. KS is an employee of Consultech. HVN was an employee of Grünenthal when he contributed to the protocol and reports personal fees from Medwis-extern GmbH & Co.KG, outside the submitted work. JMV is an employee of ESTEVE Pharmaceuticals. KV reports personal fees from Bayer Healthcare, Grünenthal, Eli Lilly and Company, and AbbVie, outside the submitted work. JV reports personal fees from Casquar, outside the submitted work. RDT reports personal fees from Bayer, Grünenthal, GSK, and Sanofi outside the submitted work. In addition, he has a patent DE 103 31 250.1-35 with royalties paid by MRC Systems. MRC Systems (BP and MG) develop, produce, and market products in the field of QST.